Literature DB >> 2526033

Carbohydrate metabolism in HT29 colon cancer cells cultured in a glucose free medium supplemented with inosine.

T Gauthier1, C Denis-Pouxviel, J C Murat.   

Abstract

1. Carbohydrate metabolism was studied in HT29 human colon cancer cells cultured in a glucose free medium supplemented with 2.8 mM inosine (HT29ino cells) in comparison with standard HT29 cells grown in the permanent presence of glucose (HT29Glc + cells) and with HT29Glc- cells which are adapted to grow permanently without glucose. 2. Inosine allows the standard cells to grow when glucose is lacking but surprisingly stops the growth of HT29Glc- cells. 3-mercaptopicolinate, an inhibitor of PEP-carboxykinase, does not hinder HT29ino cells to grow, which shows that gluconeogenesis from aspartate or pyruvate is not essential. It suggests that enough carbohydrate is supplied by the ribose moiety of inosine. 3. While standard HT29Glc + cells are highly glycolytic, it is not the case of HT29ino or HT29Glc- cells when glucose is given for few hours. When glucose is present for 24 hr or more, glycolytic rate increases in HT29ino cells and glycogen accumulates. 4. It is found that the pattern of enzymes activities related to carbohydrate metabolism in HT29ino cells is closer to that of HT29Glc + cells rather than to that of HT29Glc- cells. However, phosphofructokinase-1 activity, measured with saturating concentration of Fru-2,6-diP, is significantly lower in HT29ino cells. 5. Binding rate of hexokinase to mitochondria is similar in the three cell-lines. However, in HT29Glc- cells, bound hexokinase easily utilizes ATP generated by the mitochondria. By contrast, in HT29Glc+ and HT29ino cells, bound hexokinase is much more active with exogenous ATP, suggesting a functional defect in the mitochondria from these two latter cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526033     DOI: 10.1016/0020-711x(89)90108-0

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  4 in total

Review 1.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

2.  Effect of purine supplementation on the growth of salmonid cell lines in different mammalian sera.

Authors:  R C Ganassin; N C Bols
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  PCK2 activation mediates an adaptive response to glucose depletion in lung cancer.

Authors:  K Leithner; A Hrzenjak; M Trötzmüller; T Moustafa; H C Köfeler; C Wohlkoenig; E Stacher; J Lindenmann; A L Harris; A Olschewski; H Olschewski
Journal:  Oncogene       Date:  2014-03-17       Impact factor: 9.867

4.  Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD82 Cell Line.

Authors:  Shuo Wang; Jiang Chen; Hongyu Li; Xingshun Qi; Xu Liu; Xiaozhong Guo
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.